Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine vs Diphenhydramine for Paclitaxel Premedication
NCT04237090Phase 3Completed
- Start
- Feb 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cetirizine in Infusion-related reactions. Primary endpoints: Change from baseline of drowsiness on Stanford Sleepiness Scale 1 hour after administration, Change from baseline of drowsiness on Stanford Sleepiness Scale upon arrival at home at Day 1 and 3 more. Started Feb 2020; status: completed.
02
Drugs
cetirizine
03
Conditions
Infusion-related reactions
Beyond the preview
Go deeper on NCT04237090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04237090.